Gurland BJ, Wilder DE, Lantigua R.
et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry.1999;14:481-493.
Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW. Incidence and prevalence of dementia in a multiethnic cohort of municipal
Tang MX, Cross P, Andrews H.
et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians
in northern Manhattan. Neurology.2001;56:49-56.
Campion D, Flaman JM, Brice A.
et al. Mutations of the presenilin I gene in families with early-onset Alzheimer's
disease. Hum Mol Genet.1995;4:2373-2377.
Campion D, Dumanchin C, Hannequin D.
et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic
heterogeneity, and mutation spectrum. Am J Hum Genet.1999;65:664-670.
Finckh U, Muller-Thomsen T, Mann U.
et al. High prevalence of pathogenic mutations in patients with early-onset
dementia detected by sequence analyses of four different genes. Am J Hum Genet.2000;66:110-117.
St George-Hyslop PH. Molecular genetics of Alzheimer's disease. Biol Psychiatry.2000;47:183-199.
Aldudo J, Bullido MJ, Arbizu T, Oliva R, Valdivieso F. Identification of a novel mutation (Leu282Arg) of the human presenilin
1 gene in Alzheimer's disease. Neurosci Lett.1998;240:174-176.
Crook R, Ellis R, Shanks M.
et al. Early-onset Alzheimer's disease with a presenilin-1 mutation at the
site corresponding to the Volga German presenilin-2 mutation. Ann Neurol.1997;42:124-128.
Jacquier M, Arango D, Cruts M.
et al. Presenilin mutations in a Colombian familial and sporadic AD sample. Neurobiology of Aging.2000;21(1S):S176.
Lendon CL, Martinez A, Behrens IM.
et al. E280A PS-1 mutation causes Alzheimer's disease but age of onset is
not modified by ApoE alleles. Hum Mutat.1997;10:186-195.
Ramirez-Duenas MG, Rogaeva EA, Leal CA.
et al. A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family
with early onset Alzheimer disease. Ann Genet.1998;41:149-153.
Tang MX, Stern Y, Marder K.
et al. The APOE-∊4 allele and the risk of Alzheimer disease among African
Americans, whites, and Hispanics. JAMA.1998;279:751-755.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA
Work Group under the auspices of Department of Health and Human Services Task
Force on Alzheimer's Disease. Neurology.1984;34:939-944.
Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile
change in the cerebral grey matter of elderly subjects. Br J Psychiatry.1968;114:797-811.
Pittman J, Andrews H, Tatemichi T.
et al. Diagnosis of dementia in a heterogeneous population: a comparison of
paradigm-based diagnosis and physician's diagnosis. Arch Neurol.1992;49:461-467.
Stern Y, Andrews H, Pittman J.
et al. Diagnosis of dementia in a heterogeneous population: development of
a neuropsychological paradigm-based diagnosis of dementia and quantified correction
for the effects of education. Arch Neurol.1992;49:453-460.
Stricks L, Pittman J, Jacobs DM, Sano M, Stern Y. Normative data for a brief neuropsychological battery administered
to English- and Spanish-speaking community-dwelling elders. J Int Neuropsychol Soc.1998;4:311-318.
Roman GC, Tatemichi TK, Erkinjuntti T.
et al. Vascular dementia: diagnostic criteria for research studies: report
of the NINDS-AIREN International Workshop. Neurology.1993;43:250-260.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry.1982;140:566-572.
Alzheimer's Disease Collaborative Group. The structure of the presenilin 1 (S182) gene and identification of
six novel mutations in early onset AD families. Nat Genet.1995;11:219-222.
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint
approach. Am J Hum Genet.1996;58:1347-1363.
Cottingham Jr RW, Idury RM, Schaffer AA. Faster sequential genetic linkage computations. Am J Hum Genet.1993;53:252-263.
Lathrop GM, Lalouel JM. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet.1984;36:460-465.
Terwilliger J, Ott J. Handbook of Human Genetic Linkage. Baltimore, Md: Johns Hopkins University Press; 1994.
Goring HH, Terwilliger JD. Linkage analysis in the presence of errors, III: marker loci and their
map as nuisance parameters. Am J Hum Genet.2000;66:1298-1309.
Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered.2000;50:133-139.
Citron M, Westaway D, Xia W.
et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue
amyloid beta-protein in both transfected cells and transgenic mice. Nat Med.1997;3:67-72.
Zhang L, Song L, Parker EM. Calpain inhibitor I increases beta-amyloid peptide production by inhibiting
the degradation of the substrate of gamma-secretase: evidence that substrate
availability limits beta-amyloid peptide production. J Biol Chem.1999;274:8966-8972.
Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification
and cleavage with HhaI. J Lipid Res.1990;31:545-548.
Maestre G, Ottman R, Stern Y.
et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic
risks. Ann Neurol.1995;37:254-259.
Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated
Data. Heidelberg, Germany: Springer-Verlag; 1997.
Rogaeva EI, Sherrington R, Rogaeva EA.
et al. Familial Alzheimer's disease in kindreds with missense mutations in
a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature.1995;376:775-758.
Sherrington R, Rogaev EI, Liang Y.
et al. Cloning of a gene bearing missense mutations in early-onset familial
Alzheimer's disease. Nature.1995;375:754-760.
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol.1999;56:303-308.
Rogaeva EA, Fafel KC, Song YQ.
et al. Screening for PS1 mutations in a referral-based series of AD cases:
21 novel mutations. Neurology.2001;57:621-625.
Aldudo J, Bullido MJ, Valdivieso F. DGGE method for the mutational analysis of the coding and proximal
promoter regions of the Alzheimer's disease presenilin-1 gene: two novel mutations. Hum Mutat.1999;14:433-439.
De Jonghe C, Cruts M, Rogaeva EA.
et al. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile
Alzheimer's disease by increased Aβ42 secretion. Hum Mol Genet.1999;8:1529-1540.
Cruts M, Van Duijn CM, Backhovens H.
et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations
in a population-based study of presenile Alzheimer disease. Hum Mol Genet.1998;7:43-51.
Tysoe C, Whittaker J, Xuereb J.
et al. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed
early-onset Alzheimer disease. Am J Hum Genet.1998;62:70-76.
Kwok JB, Taddei K, Hallupp M.
et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's
disease pedigrees and preliminary evidence for association of presenilin-1
mutations with a novel phenotype. Neuroreport.1997;8:1537-1542.
Tanahashi H, Kawakatsu S, Kaneko M, Yamanaka H, Takahashi K, Tabira T. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's
disease patients. Neurosci Lett.1996;218:139-141.
Hutton M, Hardy J. The presenilins and Alzheimer's disease. Hum Mol Genet.1997;6:1639-1646.
Pons FM. The Dominican Republic: A National History. Princeton, NJ: Markus Wiener Publishers Inc; 1998.
Mayeux R, Saunders AM, Shea S.
et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's
disease. N Engl J Med.1998;338:506-511. [published correction appears in N Engl J Med. 1998;338:1325].